{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:37:39Z","timestamp":1789843059949,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014825","name":"Biotechnology Industry Research Assistance Council","doi-asserted-by":"publisher","award":["BT\/NBM\/0097\/02\/18"],"award-info":[{"award-number":["BT\/NBM\/0097\/02\/18"]}],"id":[{"id":"10.13039\/501100014825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128157","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:19:44Z","timestamp":1766517584000},"page":"128157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pneumococcal baseline IgG antibody levels and immune response to 23-valent pneumococcal polysaccharide vaccine among Indian adults"],"prefix":"10.1016","volume":"73","author":[{"given":"Shincy M.","family":"Ramakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feroze A.","family":"Ganaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Govindan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhila M","family":"Mavupadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vani","family":"Rajashekaraiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128157_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.128157_bb0010","first-page":"11","article-title":"The burden of Streptococcus pneumoniae-related admissions and in-hospital mortality: a retrospective observational study between the years 2015 and 2022 from a southern Italian province","author":"Cedrone","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.128157_bb0015","first-page":"216","article-title":"Pneumococcal disease burden from an Indian perspective: need for its prevention in pulmonology practice","volume":"36","author":"Koul","year":"2019","journal-title":"Lung India"},{"key":"10.1016\/j.vaccine.2025.128157_bb0020","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.4103\/lungindia.lungindia_272_20","article-title":"Clinical practice guidelines 2019: Indian consensus-based recommendations on pneumococcal vaccination for adults","volume":"37","author":"Dhar","year":"2020","journal-title":"Lung India"},{"key":"10.1016\/j.vaccine.2025.128157_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2012.04.006","article-title":"Invasive pneumococcal disease associated with high case fatality in India","volume":"66","author":"Thomas","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2025.128157_bb0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jmii.2018.03.004","article-title":"Invasive pneumococcal disease in Indian adults: 11 years\u2019 experience","volume":"52","author":"Jayaraman","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2025.128157_bb0035","series-title":"The pneumococcus","first-page":"30","author":"Capsule","year":"2004"},{"key":"10.1016\/j.vaccine.2025.128157_bb0040","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2025.128157_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105085","article-title":"Novel pneumococcal capsule type 33E results from the inactivation of glycosyltransferase WciE in vaccine type 33F","volume":"299","author":"Ganaie","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2025.128157_bb0050","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1016\/j.vaccine.2011.06.056","article-title":"The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A","volume":"29","author":"Cooper","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128157_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2235238","article-title":"The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C","volume":"19","author":"Shi","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128157_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vhri.2018.03.003","article-title":"Modeling possible inclusion of pneumococcal conjugate vaccine into the national immunization program for infants in India","volume":"15","author":"Ghia","year":"2018","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.vaccine.2025.128157_bb0065","first-page":"345","article-title":"Expert Group of the Association of physicians of India on adult immunization in I. The Association of Physicians of India evidence-based clinical practice guidelines on adult immunization","volume":"57","year":"2009","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.vaccine.2025.128157_bb0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2471\/BLT.21.287390","article-title":"Vaccination coverage among older adults: a population-based study in India","volume":"100","author":"Rizvi","year":"2022","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2025.128157_bb0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/CVI.00735-14","article-title":"Use and clinical interpretation of pneumococcal antibody measurements in the evaluation of humoral immune function","volume":"22","author":"Daly","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2025.128157_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jim.2018.08.002","article-title":"Measuring immune responses to pneumococcal vaccines","volume":"461","author":"LaFon","year":"2018","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2025.128157_bb0085","first-page":"514","article-title":"Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2025.128157_bb0090","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1016\/j.vaccine.2023.04.074","article-title":"Estimation of baseline IgG antibody levels to 23 pneumococcal vaccine-type capsular polysaccharides in healthy vaccine naive Indian adults","volume":"41","author":"Govindan","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128157_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.arbres.2022.12.015","article-title":"Pneumococcal vaccination in adults: what can we learn from observational studies that evaluated PCV13 and PPV23 effectiveness in the same population?","volume":"59","author":"Dunne","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.vaccine.2025.128157_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.717873","article-title":"Diagnostic vaccination in clinical practice","volume":"12","author":"Hansen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.128157_bb0105","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1128\/CVI.00259-14","article-title":"Association between serotype-specific antibody response and serotype characteristics in patients with pneumococcal pneumonia, with special reference to degree of encapsulation and invasive potential","volume":"21","author":"Athlin","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2025.128157_bb0110","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"1","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2025.128157_bb0115","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4161\/hv.21571","article-title":"Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland","volume":"8","author":"Grzesiowski","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128157_bb0120","first-page":"51","article-title":"Immune responses to pneumococcal vaccines in children and adults: rationale for age-specific vaccination","volume":"3","author":"Westerink","year":"2012","journal-title":"Aging Dis"},{"key":"10.1016\/j.vaccine.2025.128157_bb0125","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.vaccine.2009.11.011","article-title":"Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance","volume":"28","author":"Balloch","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128157_bb0130","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the basic and clinical immunology interest section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2025.128157_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267051","article-title":"Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in indigenous and non-indigenous adults","volume":"17","author":"Gaultier","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2025.128157_bb0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/431524","article-title":"Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study","volume":"192","author":"Goldblatt","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128157_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.613287","article-title":"Sugar-coated killer: serotype 3 pneumococcal disease","volume":"10","author":"Luck","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.128157_bb0150","article-title":"Baseline pneumococcal IgG levels and response to 23-valent pneumococcal polysaccharide vaccine among adults from Beijing, China","volume":"11","author":"Zhou","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.128157_bb0155","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2336358","article-title":"State of pneumococcal vaccine immunity","volume":"20","author":"Akkoyunlu","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128157_bb0160","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults","volume":"201","author":"Musher","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128157_bb0165","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the advisory committee on immunization practices (ACIP)","volume":"63","author":"Tomczyk","year":"2014","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.128157_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7203a1","article-title":"Pneumococcal vaccine for adults aged \u226519 years: recommendations of the advisory committee on immunization practices, United States, 2023","volume":"72","author":"Kobayashi","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2025.128157_bb0175","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/CVI.00112-06","article-title":"Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies","volume":"13","author":"Burton","year":"2006","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:18:59Z","timestamp":1773929939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":35,"alternative-id":["S0264410X25014550"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128157","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal baseline IgG antibody levels and immune response to 23-valent pneumococcal polysaccharide vaccine among Indian adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128157"}}